Vanguard Global Advisers’s Carlsmed CARL Stock Holding History

Vanguard Global Advisers’s Portfolio CARL Stock Details CARL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.1K	Hold	3,577	–	–	﹤0.01%	3163
2026 Q1	$32.4K	Buy	+3,577	New	+$43.2K	﹤0.01%	3176

Other funds holding CARL

Jupiter Topco New York $245B AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM Capital Shawnee, Kansas $618M AUM

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Global Advisers's CARL Position: Q2 2026 in Review

Vanguard Global Advisers held its Carlsmed (CARL) position steady in Q2 2026 at 3,577 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

Vanguard Global Advisers first reported a position in CARL in Q1 2026 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

Vanguard Global Advisers held 3,577 shares of Carlsmed worth $37.1K as of Q2 2026.
Vanguard Global Advisers left its Carlsmed share count unchanged in Q2 2026.
Carlsmed made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3163 holding.
Vanguard Global Advisers first reported a position in Carlsmed in Q1 2026 and has held it in 2 quarters since.
75 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.